|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00680355 |
|
Date of registration:
|
16/05/2008 |
|
Primary sponsor: |
|
|
Public title:
|
Bioavailability of Golden Rice Carotenoids in Humans
|
|
Scientific title:
|
Bioavailability of Golden Rice Carotenoids in Humans |
|
Date of first enrolment:
|
August 2004 |
|
Target sample size:
|
15 |
|
Recruitment status: |
Recruiting |
|
URL:
|
http://clinicaltrials.gov/show/NCT00680355 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
|
|
|
Countries of recruitment
|
|
United States
| | | | | | | |
|
Contacts
|
|
Name:
|
Guangwen Tang, Ph.D |
|
Address:
|
|
|
Telephone:
|
617-556-3236 |
|
Email:
|
guangwen.tang@tufts.edu |
|
Affiliation:
|
|
|
|
Name:
|
guangwen tang, Ph. D. |
|
Address:
|
|
|
Telephone:
|
617-556-3236 |
|
Email:
|
guangwen.tang@tufts.edu |
|
Affiliation:
|
|
|
|
Name:
|
Guangwen Tang, Ph. D |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Tufts University |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- healthy health
Exclusion Criteria:
- GI track problems
Age minimum:
40 Years
Age maximum:
70 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Healthy
|
|
Intervention(s)
|
|
Dietary Supplement: golden rice
|
|
Primary Outcome(s)
|
|
The enrichment of labeled golden rice ß-carotene and its conversion to labeled retinol in serum samples after the golden rice meal with 0, 5, or 10 g fat (butter) as compared to the reference dose of vitamin A that is labeled differently.
[Time Frame: 33 days]
|
|
Secondary ID(s)
|
|
59-1956-6-656
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|